{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T02:50:22.823792",
  "document": "Pancreatic-Neuroendocrine-Neoplasms-(pNENs).pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/test/Pancreatic-Neuroendocrine-Neoplasms-(pNENs).pdf",
  "pipeline_version": "0.8",
  "total_candidates": 3,
  "total_validated": 3,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "diseases": [
    {
      "matched_text": "pNEN",
      "preferred_label": "Neuroendocrine neoplasm of pancreas",
      "abbreviation": "PNEN",
      "confidence": 0.95,
      "is_rare_disease": true,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": "2C10.1",
        "snomed": null,
        "mondo": null,
        "orpha": "ORPHA:506052",
        "umls": null,
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "ORPHA",
          "code": "ORPHA:506052",
          "display": null
        },
        {
          "system": "ICD-11",
          "code": "2C10.1",
          "display": null
        }
      ],
      "context": "PNENSs seem to affect women slightly more often than men. Individuals of any ethnic or racial group may develop a pNEN. Affected individuals usually develop sporadic pNENs between the ages of 30-60. When pNENs occur as part of a genetic syndrome, they tend to occur during childhood or young adulthood. PNENs affect approximately ~1 in 100,000 individuals in the general population per year. They account for approxima",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_rare_disease_acronyms.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "pancreatic neuroendocrine neoplasms",
      "preferred_label": "pancreatic neuroendocrine neoplasm",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005815",
        "orpha": "Orphanet:506052",
        "umls": "UMLS:C5848399",
        "mesh": null
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005815",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:1799",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0007331",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:22052",
          "display": null
        },
        {
          "system": "ICDO",
          "code": "ICDO:8150/1",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:1848937",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C27031",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:506052",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:254611009",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C5848399",
          "display": null
        },
        {
          "system": "icd11.foundation",
          "code": "icd11.foundation:1421495979",
          "display": null
        }
      ],
      "context": "he ages of 30-60. When pNENs occur as part of a genetic syndrome, they tend to occur during childhood or young adulthood. PNENs affect approximately ~1 in 100,000 individuals in the general population per year. They account for approximately 2-4 percent of all pancreatic neoplasms. A diagnosis of a pancreatic neuroendocrine neoplasms is made based upon identification of characteristic symptoms (if present), a detailed patient history, a thorough clinical evaluation and a variety of specialized tests including advanced imaging techniques (octrotide-scintigraphy, CT, MRI, PET-CT, PET-MRI), blood tests (Chromogranin A, NETest), bi",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "pancreatic neoplasms",
      "preferred_label": "pancreatic neoplasm",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0021040",
        "orpha": null,
        "umls": "UMLS:C0030297",
        "mesh": "MESH:D010190"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0021040",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0003860",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:18279",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D010190",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3305",
          "display": null
        },
        {
          "system": "ONCOTREE",
          "code": "ONCOTREE:PANCREAS",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:126859007",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0030297",
          "display": null
        }
      ],
      "context": "sually develop sporadic pNENs between the ages of 30-60. When pNENs occur as part of a genetic syndrome, they tend to occur during childhood or young adulthood. PNENs affect approximately ~1 in 100,000 individuals in the general population per year. They account for approximately 2-4 percent of all pancreatic neoplasms. A diagnosis of a pancreatic neuroendocrine neoplasms is made based upon identification of characteristic symptoms (if present), a detailed patient history, a thorough clinical evaluation and a variety of specialized tests including advanced imaging techniques (octrotide-scintigraphy, CT, MRI, PET-",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Pancreatic Intraductal Neoplasms"
      ],
      "pubtator_normalized_name": "Pancreatic Neoplasms",
      "enrichment_source": "pubtator3"
    }
  ]
}